Identify and categorize drug-related problems in hospitalized surgical patients in China

被引:31
作者
Qu, Can [1 ]
Meng, Long [1 ]
Wang, Ning [1 ]
Chen, Yong [1 ]
Yang, Xiao [1 ]
Wang, Jun [1 ]
Sun, Shusen [2 ,3 ,4 ]
Qiu, Feng [1 ]
机构
[1] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, 1 Youyi Rd, Chongqing, Peoples R China
[2] Western New England Univ, Dept Pharm Practice, Coll Pharm & Hlth Sci, 1215 Wilbraham Rd, Springfield, MA 01119 USA
[3] Cent S Univ, Dept Pharm, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[4] Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Inst Rat & Safe Medicat Practices, Changsha 410008, Hunan, Peoples R China
关键词
China; Drug-related problems; NCC-MERP classification; PCNE classification; Pharmacist; Pharmacy service; CLASSIFICATION-SYSTEM;
D O I
10.1007/s11096-018-0777-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Data is lacking on types and severities of drug-related problems (DRPs) in hospitalized surgical patients in China. Objective To identify and categorize types and causes of DRPs, and to assess severities of these DRPs. Setting An academic teaching hospital in Chongqing, China. Method We retrospectively reviewed all medication orders for patients in six surgical departments during a six-month period. DRPs were classified using the Pharmaceutical Care Network Europe(PCNE) classification, and the severity ratings of these DRPs were based on the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP)classification. Main outcome measure The number, types, causes and severities of the DRPs. Results A total of 291,944 medication orders in 10,643 patients were reviewed, and 3548 DRPs were identified. The average DRP number per patient was 0.3. The most common problem was treatment effectiveness (39.9%) and the major cause of the problems was dose selection (47.0%). Total 80.1% of the DRPs were rated at severity categories B to D (causing no or potential harm), whereas 19.9% were rated as categories E to H (causing actual harm). Conclusion DRPs are common in surgical patients, and prospective pharmacist medication order review services are needed to improve patients' pharmaceutical care.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 10 条
  • [1] Application of drug-related problem (DRP) classification systems: a review of the literature
    Basger, Benjamin J.
    Moles, Rebekah J.
    Chen, Timothy F.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (07) : 799 - 815
  • [2] Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability
    Hohmann, C.
    Eickhoff, C.
    Klotz, J. M.
    Schulz, M.
    Radziwill, R.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (03) : 276 - 281
  • [3] Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital
    Lampert, Markus L.
    Kraehenbuehl, Stephan
    Hug, Balthasar L.
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 768 - 776
  • [4] Systematic Review on Irrational Use of Medicines in China and Vietnam
    Mao, Wenhui
    Vu, Huyen
    Xie, Zening
    Chen, Wen
    Tang, Shenglan
    [J]. PLOS ONE, 2015, 10 (03):
  • [5] NCC MERP, TAX MED ERR
  • [6] Pharmaceutical Care Network Europe (PCNE), 2018, PCNE CLASS V8 02
  • [7] Epidemiology and potential risk factors of drug- related problems in Hong Kong paediatric wards
    Rashed, Asia N.
    Wilton, Lynda
    Lo, Charles C. H.
    Kwong, Benjamin Y. S.
    Leung, Suzanne
    Wong, Ian C. K.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (05) : 873 - 879
  • [8] Exploring the potential impact of hospital ward-based pharmacy interns on drug safety
    Schorr, S. G.
    Eickhoff, C.
    Feldt, S.
    Hohmann, C.
    Schulz, M.
    [J]. PHARMAZIE, 2014, 69 (04): : 316 - 320
  • [9] Clinical Usefulness of Electronic Drug-Drug Interaction Checking in the Care of Cardiovascular Surgery Inpatients
    Taegtmeyer, A. B.
    Kullak-Ublick, G. A.
    Widmer, N.
    Falk, V.
    Jetter, A.
    [J]. CARDIOLOGY, 2012, 123 (04) : 219 - 222
  • [10] WHO, MED HARM